Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Nuclear Medicine Communications|July 4, 2009
Effect of variation in relaxation parameter value on LOR-RAMLA reconstruction of 18F-FDG PET studiesDavid Groheux, Antoine Martineau, Jean-Marc Vrigneaud, et al.Clinical Nuclear Medicine|March 21, 2013
Variation of liver SUV on (18)FDG-PET/CT studies in women with breast cancerDavid Groheux, Marc Delord, Domenico Rubello, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 16, 2011
The sentinel node procedure in breast cancer: nuclear medicine as the starting pointElif Hindié, David Groheux, Isabelle Brenot-Rossi, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 12, 2017
Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patientsCharles Lemarignier, Antoine Martineau, Luis Teixeira, et al.Anticancer Research|March 10, 2015
Impact of radical surgery on outcome in locally advanced breast cancer patients without metastasis at the time of diagnosisMaryam Nikpayam, Catherine Uzan, Sofia Rivera, et al.Breast Cancer Research : BCR|January 7, 2017
18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysisDavid Groheux, Antoine Martineau, Luis Teixeira, et al.Clinical Nuclear Medicine|July 24, 2013
Role of SPECT/CT in sentinel lymph node detection in patients with breast cancerLaetitia Vercellino, Jessica Ohnona, David Groheux, et al.Bulletin Du Cancer|August 29, 2007
[Interests and perspectives of PET-CT for breast cancer: review of the literature]David Groheux, Elif Hindie, Marc Espié, et al.PET Clinics|May 10, 2016
Nuclear Medicine in Early-Stage Melanoma: Sentinel Node Biopsy-FDG-PET/CTElif Hindié, Farid Sarandi, Soraya Banayan, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 14, 2012
Triple-negative breast cancer: early assessment with 18F-FDG PET/CT during neoadjuvant chemotherapy identifies patients who are unlikely to achieve a pathologic complete response and are at a high risk of early relapseDavid Groheux, Elif Hindié, Sylvie Giacchetti, et al.Pageof 5